The metabolic effect of gut-derived metabolites coincides with the prevention of conditions like obesity and diabetes in mouse models. However, to produce the beneficial gut-derived metabolites, we need to ingest foods that contain specific bioactive compounds and have beneficial bacterial strains in our gut. Recently, pomegranate polyphenolic compounds and the combination of gut microbiota have been associated with beneficial metabolic effects on mice fed with a high-fat diet. Furthermore,Â Akkermansia muciniphila, a bacterial strain that resides in the mucosal layer of the gut, is detected in those patients with a healthier metabolic status. Therefore, this connection raises the question doesÂ Akkermansia muciniphilaÂ improves metabolic homeostasis when combined with pomegranate extract?
The beneficial effects of pomegranate extract as a prebiotic are attributed to the presence of ellagitannins. Nevertheless, ellagitannins need to be hydrolyzed by the stomach acids and then converted into ellagic acids by the intestinal enzymes. After these processes, the remaining ellagitannins and ellagic acid are metabolized into urolithin by the gut microbiota.Â
Ellagitannins are not directly absorbed into the bloodstream. On the other hand, the digestive tract where ellagitannins and ellagic acid have more presence and direct interaction with the gut microbiota. Indeed, this interaction also coincides with a beneficial alteration in the gut’s bacteria diversity and the production of urolithin A.Â
This bacterial strain constitutes 3-5% of the microbial community in healthy subjects. Recent studies associate an appropriate abundance of A. muciniphila with healthy body weight and increased muscle mass. Also, in a study where the subjects followed a low caloric diet, this bacterial strain showed consistent abundance. Besides this, several studies associate obesity and type 2 diabetes with less quantity of A. muciniphila.
Recent studies have demonstrated an increased proportion of A. muciniphila in mice fed with a high-fat/sucrose diet after drinking cranberry juice. In turn, this increase resulted in reduced weight gain and insulin resistance. Other studies reported significant contributions associated with increased A. muciniphila content; some of them are:
- Reversed high-fat diet-induced metabolic disorders.
- Reduced fat-mass gain.
- Less adipose tissue-induced inflammation.
- Increased insulin sensitivity.
- Metabolic endotoxemia prevention.
Does A. muciniphila metabolize ellagitannin to urolithin A?
Urolithin has multiple isomers; within them, urolithin A associates with numerous health benefits. An increase in this polyphenol gut-derived metabolite coincides with an attenuation of inflammatory signaling, anti-cancer effects, modulation of energetic homeostasis, and anti-aging, specifically to those mechanisms linked to mitochondrial and muscular dysfunction. Furthermore, in animal models, urolithin A increases mitophagy of dysfunctional mitochondria, followed by autophagosome formation, clearing mitochondrial protein. This mechanism improves the quality of cellular mitochondria and promotes the generation of new organelles.
However, some studies report that only 40% of people can produce meaningful amounts of urolithin A from its dietary precursors. In turn, this mechanism links to the gut microbiota diversity and A. muciniphila composition.
A small study with 18 volunteers measured the effects of 4- week intervention of pomegranate extract, the abundance of Akkermansia muciniphila, and urolithin A production.
This study concluded that those subjects with higher urolithin A production coincide with elevated A. muciniphila in their stools. On the other hand, those urolithin A-non producers had higher levels of ellagic acid in their stool samples after a 4- week intervention with pomegranate extract.
There is no doubt about the influence that gut microbiota has on metabolic health. Also, we know all about the extraordinary benefits that polyphenolic compounds provide by modulating inflammatory responses, promoting antioxidant effects, and how they stimulate the growth of beneficial bacteria. However, the apparent interaction between urolithin A production by A. municiphila merges this mechanism and provides additional effects. Furthermore, this interaction promotes mitophagy, resulting in a better mitochondrial function that equates to better energy production (ATP), joint and muscle tissue promotion, and overall health. – Ana Paola RodrÃguez Arciniega
Henning, Susanne M et al. “Pomegranate ellagitannins stimulate the growth of Akkermansia muciniphila in vivo.”Â AnaerobeÂ vol. 43 (2017): 56-60. doi:10.1016/j.anaerobe.2016.12.003
D’Amico, Davide et al. “Impact of the Natural Compound Urolithin A on Health, Disease, and Aging.”Â Trends in molecular medicineÂ vol. 27,7 (2021): 687-699. doi:10.1016/j.molmed.2021.04.009
Additional Online Links & Resources (Available 24/7)
Online Appointments or Consultations: https://bit.ly/Book-Online-Appointment
Online Physical Injury / Accident Intake Form:Â https://bit.ly/Fill-Out-Your-Online-HistoryÂ
Online Functional Medicine Assessment:Â https://bit.ly/functionmed
The information herein on "Akkermansia muciniphila: Intestine's Urolithin A Promoter." is not intended to replace a one-on-one relationship with a qualified health care professional, licensed physician, and is not medical advice. We encourage you to make your own health care decisions based on your research and partnership with a qualified health care professional.
Our information scope is limited to chiropractic, musculoskeletal, physical medicines, wellness, sensitive health issues, functional medicine articles, topics, and discussions. We provide and present clinical collaboration with specialists from a wide array of disciplines. Each specialist is governed by their professional scope of practice and their jurisdiction of licensure. We use functional health & wellness protocols to treat and support care for the injuries or disorders of the musculoskeletal system.
Our videos, posts, topics, subjects, and insights cover clinical matters, issues, and topics that relate to and support, directly or indirectly, our clinical scope of practice.*
Our office has made a reasonable attempt to provide supportive citations and has identified the relevant research study or studies supporting our posts. We provide copies of supporting research studies available to regulatory boards and the public upon request.
We understand that we cover matters that require an additional explanation of how it may assist in a particular care plan or treatment protocol; therefore, to further discuss the subject matter above, please feel free to ask Dr. Alex Jimenez or contact us at 915-850-0900.
We are here to help you and your family.